Morphine Exports from Afghanistan: International Trade Law Aspects
The Institute is undertaking a study on the international trade law aspects of potential morphine and codeine exports from Afghanistan. The Study has been commissioned by the Senlis Council, a security and development policy group that works towards establishing a sustainable system of legal opium-for-morphine production in Afghanistan. Such a system would require export channels for Afghan opium-based products, such as morphine and codeine, that are widely used in pharmaceutical industry and satisfy pain relief needs throughout the developed and developing world.
The Institute will examine the existing legal framework on international trade in morphine and codeine, including the UN Drug Conventions regime, the rules of the World Trade Organization (WTO) and the preferential trading schemes of the European Union. The Study will further explore possibilities for concluding bilateral or multilateral agreements between Afghanistan and other countries that would allow increasing exports of Afghan morphine and codeine. The particular focus of the research will be on the compatibility of such agreements with existing multilateral (UN Drug Conventions, WTO law) and regional (EU law) rules.
Research will be conducted by Dr Sergey Ripinsky and Hugo Warner under the supervision of Dr Federico Ortino.
More information on the Senlis Council's initiatives may be found on their website.
If you would like to receive updates on developments at the Institute in future, please sign up to this site, specifying your areas of interest.
